Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Maspero

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Allergy|March 17, 2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA<sup>2</sup> LEN consensusJan Hagemann, Gabrielle L Onorato, Marek Jutel, et al.
Allergy|June 11, 2017
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)J Bousquet, I Agache, M R Aliberti, et al.
Clinical and Translational Allergy|September 14, 2019
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseasesJ Jean Bousquet, Holger J Schünemann, Alkis Togias, et al.
Allergy|June 9, 2020
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practiceJean Bousquet, Josep M Anto, Claus Bachert, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Allergy|March 17, 2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA<sup>2</sup> LEN consensusJan Hagemann, Gabrielle L Onorato, Marek Jutel, et al.
Allergy|June 11, 2017
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)J Bousquet, I Agache, M R Aliberti, et al.
Clinical and Translational Allergy|September 14, 2019
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseasesJ Jean Bousquet, Holger J Schünemann, Alkis Togias, et al.
Allergy|June 9, 2020
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practiceJean Bousquet, Josep M Anto, Claus Bachert, et al.
Pageof 6